全面关节镜治疗盂肱骨关节炎的生存率与患者报告结局:至少10年随访
该病例系列研究对38例接受全面关节镜治疗(CAM)的晚期盂肱骨关节炎(GHOA)患者进行至少10年随访,5年生存率为75.3%,至少10年生存率为63.2%。未转为关节置换者美国肩肘外科医师评分在5年和10年随访时均显著改善,肱骨头严重不匹配与CAM失败相关。
要点
- CAM术后5年生存率75.3%,至少10年生存率63.2%,失败者平均4.7年转为关节置换。
- 未转为关节置换者美国肩肘外科医师评分从术前63.3改善至5年89.6和10年80.6。
- 93.8%的失败病例存在术前肱骨头严重不匹配,显著高于未转为关节置换者的50.0%。
核心结论
- 对于接受CAM手术的年轻GHOA患者,患者报告结局在至少10年随访时维持显著改善。
- 至少10年随访的生存率为63.2%。
- 肱骨头变平和严重关节不匹配是CAM失败的危险因素。
- CAM手术是经过适当选择的GHOA患者有效的关节保留治疗方法,10年时结局持续积极。
研究设计与样本
- 病例系列研究,证据等级3级。
- 对连续系列晚期GHOA且符合全肩关节置换术标准但选择关节保留手术的患者实施CAM手术。
- 共38例CAM手术完成至少10年随访(范围10-14年),手术时平均年龄53岁(范围27-68岁)。
主要发现
- 5年生存率为75.3%,至少10年生存率为63.2%。
- 转为关节置换者平均在4.7年(范围0.8-9.6年)进行手术。
- 未转为关节置换者美国肩肘外科医师评分从术前63.3显著改善至5年89.6(P < .001)和10年80.6(P = .007)。
- CAM失败与术前肱骨头严重不匹配相关:失败病例中占93.8%,未转为关节置换者中占50.0%(P = .008)。
- 满意度中位数为7.5分(满分10分)。
关键数值与推荐
- 生存率:5年75.3%,至少10年63.2%。
- 美国肩肘外科医师评分:术前63.3,5年89.6(P < .001),10年80.6(P = .007)。
- 术前肱骨头严重不匹配比例:失败病例93.8% vs 未转为关节置换者50.0%(P = .008)。
- 满意度中位数7.5/10。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Few long-term outcome studies exist evaluating glenohumeral osteoarthritis (GHOA) treatment with arthroscopic management. PURPOSE: To determine outcomes, risk factors for failure, and survivorship for the comprehensive arthroscopic management (CAM) procedure for the treatment of GHOA at minimum 10-year follow-up. STUDY DESIGN: Case series; Level of evidence, 3. METHODS: The CAM procedure was performed on a consecutive series of patients with advanced GHOA who opted for joint preservation surgery and otherwise met criteria for total shoulder arthroplasty. At minimum 10-year follow-up, postoperative outcome measures included change in the American Shoulder and Elbow Surgeons, Single Assessment Numeric Evaluation, 12-Item Short Form Health Survey (SF-12) Physical Component Summary, and visual analog scale for pain, along with the QuickDASH (shortened version of Disabilities of the Arm, Shoulder and Hand) and satisfaction score. Kaplan-Meier survivorship analysis was performed, with failure defined as progression to arthroplasty. RESULTS: In total, 38 CAM procedures were performed with 10-year minimum follow-up (range, 10-14 years) with a mean patient age of 53 years (range, 27-68 years) at the time of surgery. Survivorship was 75.3% at 5 years and 63.2% at minimum 10 years. Those who progressed to arthroplasty did so at a mean 4.7 years (range, 0.8-9.6 years). For those who did not undergo arthroplasty, American Shoulder and Elbow Surgeons scores significantly improved postoperatively at 5 years (63.3 to 89.6; P < .001) and 10 years (63.3 to 80.6; P = .007). CAM failure was associated with severe preoperative humeral head incongruity in 93.8% of failures as compared with 50.0% of patients who did not go on to arthroplasty (P = .008). Median satisfaction was 7.5 out of 10. CONCLUSION: Significant improvements in patient-reported outcomes were sustained at minimum 10-year follow-up in young patients with GHOA who underwent a CAM procedure. The survivorship rate at minimum 10-year follow-up was 63.2%. Humeral head flattening and severe joint incongruity were risk factors for CAM failure. The CAM procedure is an effective joint-preserving treatment for GHOA in appropriately selected patients, with sustained positive outcomes at 10 years.
引用
- Arner JW, Elrick BP, Nolte PC, et al. Survivorship and Patient-Reported Outcomes After Comprehensive Arthroscopic Management of Glenohumeral Osteoarthritis: Minimum 10-Year Follow-up. Am J Sports Med. 2020. PMID: 33175562. doi:10.1177/0363546520962756
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。